Latest Breaking News On - நாளமில்லா பதில் ப்ரிடிக்டர் - Page 1 : comparemela.com

The tool developed on the basis of the ADAPT study data will be presented today at SABCS 2020 Cologne, Germany, 11.12.2020 – The EnReP (Endocrine Response Predictor) assessment tool will be presented today at the San Antonio Breast Cancer Symposium SABCS 2020. EnReP is a tool developed in Germany that can be used to predict the probability of response to endocrine therapy in early-stage breast cancer patients. Endocrine therapy is the standard therapy for hormone receptor-positive (HR+) / HER2-negative (HER2-) breast cancer patients. The ADAPT study program evaluates options for patient-specific decision-making for breast cancer treatment based on modern biological markers. A central component here is the examination of the tumor’s response to a brief anti-hormone therapy prior to operation.

West germanUniversity hospital munichSenology clinic interdisciplinary breast cancer centerOleg gluz breast center niederrheinHarbeck breast centerGerman study groupUlrike nitz breast center niederrheinHead global business developmentNadia harbeck breast centerService gmbEndocrine response predictorSan antonio breast cancer symposiumBreast centerWest german study groupBreast center niederrheinSenology clinic